Weekend ICYMI: July 15 to July 19
In case you missed it, this week we had news about cybersecurity breaches at Rite Aid, advancements in chronic hand eczema treatment, the Superman Pharmacist, and more.
Rite Aid Addresses Cyberattack: 2.2 Million Customers’ Data Breached
On July 16, 2024, Rite Aid reported a cybersecurity breach that occurred last month on June 6. Although the company maintains that Social Security and financial information were not breached—just data from the purchase or attempted purchase products—up to 2.2 million customers’ data may have been affected.
Visual of digital cybersecurity and network protection / adam121 - stock.adobe.com
Chronic Hand Eczema Treatment Shows Positive Results in Phase 3 Trials
Positive results from two phase 3 trials evaluating the safety and efficacy of twice-daily delgocitinib cream for the treatment of adult patients with moderate to severe chronic hand eczema have been announced, according to a release from LEO Pharmaceuticals. Results from the DELTA 1 (NCT04871711) and DELTA 2 (NCT04872101) trials showed that twice-daily delgocitinib cream met its primary endpoint of an Investigator’s Global Assessment for chronic hand eczema treatment success score of 0 or 1.
Q&A: What the NCPA is Doing to Fight Back Against PBMs
On a recent episode of Over the Counter, Steve Postal, JD, Director of Policy and Regulatory Affairs at the National Community Pharmacists Association (NCPA), sat down with Drug Topics to discuss his organization’s work to introduce pharmacy benefit manager reform. From resources made available for its members to class-action lawsuits and several legislative bills in the works, read about the NCPA’s fight to reclaim revenue for community pharmacists.
Emporos, InterLink AI Partnership to Revolutionize POS in the Pharmacy
Combining a point of sale (POS) system with scripClip’s lighted pharmacy will-call system, the newly announced partnership between Emporos and InterLink AI will allow pharmacists to streamline tasks, free up their time around the pharmacy, and—crucially—improve patient care with swift yet valued care and services. “Our partnership with Emporos reinforces the vision we share: to make the pharmacy experience more efficient and safer, for the health of pharmacies and their patients everywhere,” said Dan Gordon, InterLink AI President and CEO.
The Girls Are Back: One Pharmacist’s Journey to Save His Community Pharmacy
“Ever since I was a child,” Mayank Amin, PharmD, RPh, MBA, owner and chief patient advocate of Skippack Pharmacy, recalls, “I always wanted to do something that could make a big impact in the lives of those around me.” This wish would guide his career.
A must-listen for any pharmacist struggling to find positivity in the profession, Amin—also known as the Superman Pharmacist—sat down with Drug Topics on part 1 of an episode of Over the Counter to share his experiences transforming a shuttered independent pharmacy into a thriving community hub.
Are you ready to elevate your pharmacy practice? Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips, straight to your inbox.
